about
cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injuryPost-Translational Modifications of Cardiac Mitochondrial Proteins in Cardiovascular Disease: Not Lost in TranslationThe protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stressMitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseasesHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesMitochondrial Quality Control in Cardiac DiseasesIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseasesMonoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart SurgeryHeart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathyA Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial CardiotoxicitySilent disease progression in clinically stable heart failure.Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory SupportImpact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodelingMitochondrial proteome remodeling in ischemic heart failureThe Structure-function remodeling in rabbit hearts of myocardial infarctionAgonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injuryA novel role of exogenous carbon monoxide on protecting cardiac function and improving survival against sepsis via mitochondrial energetic metabolism pathway.Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling.Mitochondria-targeting particles.Mitochondrial morphological features are associated with fission and fusion eventsAldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1ATP synthase subunit alpha and LV mass in ischaemic human hearts.Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment.Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure.cJun N-terminal kinase (JNK) phosphorylation of serine 36 is critical for p66Shc activationEffect of limb demand ischemia on autophagy and morphology in mice.Caffeic acid ethanolamide prevents cardiac dysfunction through sirtuin dependent cardiac bioenergetics preservation.Novel Roles of Epoxyeicosanoids in Regulating Cardiac Mitochondria.Novel Insights into the PKCβ-dependent Regulation of the Oxidoreductase p66Shc.Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.Grip Strength as a Marker of Hypertension and Diabetes in Healthy Weight Adults.Successful aging: Advancing the science of physical independence in older adults.Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice.Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure.Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes.Heme levels are increased in human failing heartsDefect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency.
P2860
Q24596767-FFC16DEC-37B5-40D5-8BBC-B24EFCAEC16AQ26769979-AAFA417C-94F2-424A-AEEA-31E24AB10CFAQ26822734-26EAA780-8D20-443C-9F18-416A42ECBDF9Q26866951-63DA6E23-02DB-4EB1-88D0-5BC145A6798AQ27005955-9B6E6038-F5D3-4093-806B-C17167D50212Q28072801-2FDE0C91-EFDD-473F-A124-7FB9725A4F2AQ28088503-AEF6D130-F706-4B9E-887C-AD4436B396C4Q28088780-E1A2691F-967A-4455-A344-41AF3B7DAB98Q28395925-9A3C2A08-5619-4715-AC21-D34E17C5F3D6Q28544978-B1283BC9-055F-4227-8DA8-16E30413AB21Q28553631-41866B19-1085-4E18-9820-4A303F35323CQ33578212-B2BD0048-3D58-4B85-BB1D-04BAA8E11B0AQ33677357-38ECA867-A559-4134-9EA2-7932CC581918Q33775560-057A85AA-372C-4840-9461-7CD1BD9A15D4Q33822885-81974A52-0AB7-496D-B2F7-BC2829308F70Q33856650-C6E8917B-9E5A-4005-9F73-775941020BC4Q33943971-15E895F9-BCCE-48C7-BB3A-51969C14FD3BQ33970180-1CB0F48B-04F0-4A14-86B4-1D6761E43156Q34137983-40EC6685-0706-4360-8A03-916FB71E7760Q34960940-4460A2FE-9B14-48B6-A454-40B8F231F9FCQ35148029-001C52D0-842B-4B58-A3AF-6D6C7B513062Q35510238-F5AEDC55-D5AF-4334-ABE7-AAE862337830Q35531382-93B3DD7A-A6B1-43AE-928C-BCA8785C2A4AQ35657024-3BFB091E-B0D3-4AD5-A04B-FEE84D81C70BQ35893494-C10B9D22-671D-4A09-80EC-C011322EF016Q35921419-43B2CF15-0D3C-4DD7-8319-A076520AC102Q36030804-67FB54D8-CFA6-4CA3-80BB-B26F75877281Q36081808-C4C72B0C-9746-4506-871B-8FC1F8814860Q36096020-2AC0C0D3-FCF1-4CAA-BB46-6E12F27AAB80Q36131918-15BA603B-27BF-48AC-92DF-E83195F7ABE9Q36141698-F2C16ABD-62FD-4DA6-B597-6EEBC7178B03Q36263372-A88D7299-C802-4027-8F7D-87EC6675EDCCQ36269609-D5ACDBFF-B928-4F3E-8545-66E3134B3886Q36307683-ED113033-397A-4DE1-9F68-8F8030BEA459Q36322590-908DE5DD-358F-44F3-9E48-E752AD18879DQ36747612-17697768-265A-437C-A11A-D6F527BBE576Q36775314-F5635633-310B-4A40-9BFD-BE07715DA277Q36822397-968C3B55-72DC-4C98-A516-CA88ED1EFEC3Q37085606-4E4CAD01-1BA8-4D51-B6ED-C5CFF6CE0894Q37148737-59DDB9D2-AE68-4A41-B8D0-17108A8E4A57
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mitochondria as a therapeutic target in heart failure
@ast
Mitochondria as a therapeutic target in heart failure
@en
Mitochondria as a therapeutic target in heart failure
@nl
type
label
Mitochondria as a therapeutic target in heart failure
@ast
Mitochondria as a therapeutic target in heart failure
@en
Mitochondria as a therapeutic target in heart failure
@nl
prefLabel
Mitochondria as a therapeutic target in heart failure
@ast
Mitochondria as a therapeutic target in heart failure
@en
Mitochondria as a therapeutic target in heart failure
@nl
P2860
P3181
P1476
Mitochondria as a therapeutic target in heart failure
@en
P2093
Hossein Ardehali
Marina Bayeva
P2860
P304
P3181
P356
10.1016/J.JACC.2012.08.1021
P407
P577
2013-02-12T00:00:00Z